Loading company…
MitoRx Therapeutics develops medicines for degenerative diseases linked to mitochondrial dysfunction.
Founded in Oxfordshire in 2021, MitoRx Therapeutics develops medicines targeting degenerative diseases associated with mitochondrial dysfunction, including metabolic and neurodegenerative diseases. In November 2021, it raised GBP 1.56 million in seed funding led by UK Innovation & Science Seed Fund, with participation from Fink Family Foundation and Longevity Tech Fund.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in